Astellas

Astellas, a Pharmaceutical Preparation Manufacturing company based in Japan, reported total Scope 1, 2, and 3 emissions of 1,384,156,000 kg CO2e in 2024. This includes Scope 1 emissions of 52,212,000 kg CO2e, Scope 2 emissions of 55,621,000 kg CO2e, and Scope 3 emissions of 1,276,323,000 kg CO2e.

Looking back, Astellas's total emissions were approximately 1,243,600,000 kg CO2e in 2023, 1,011,261,000 kg CO2e in 2022, 796,161,000 kg CO2e in 2021, and 391,438,000 kg CO2e in 2020. In 2019, total emissions were 396,091,000 kg CO2e, and in 2018, they were 416,278,000 kg CO2e. The company reported total emissions of 490,000,000 kg CO2e in 2017 and 200,953,000 kg CO2e in 2015.

Astellas is committed to ambitious climate targets. The company aims to achieve Net Zero GHG emissions by 2050. Astellas has committed to Science Based Targets initiative (SBTi) aligned targets. These include reducing absolute Scope 1 and 2 GHG emissions by 63% by fiscal year 2030 from a fiscal year 2015 base year, and reducing absolute Scope 3 GHG emissions by 37.5% by fiscal year 2030 from a fiscal year 2015 base year. These Scope 1 and 2 targets are consistent with reductions required to keep global warming to 1.5°C.